Wikipedia:Peer review/Sildenafil/archive1

This peer review discussion has been closed.
The article is currently the Pharmacology Collaboration of the Month. I am also nominating it for peer review during this process so that we could also get some eyes on it (both individuals familiar with drug-related articles, and others, familiar with the copyeditting process as a whole) as it is improved towards FA or GA status. Dr. Cash (talk) 21:41, 4 August 2008 (UTC)[reply]

Ruhrfisch comments: Very briefly, here are some suggestions for improvement. If you want more comments, please ask here.

  • The lead should be an accessible and inviting overview of the whole article. My rule of thumb is to include every header in the lead in some way - the lead should be 2 or 3 paragraphs per WP:LEAD
  • Article is full of citation needed tags and should have these refs provided. My rule of thumb is that every quote, every statistic, every extraordinary claim and every paragraph needs a ref. Ref 20 is just a link - most refs are nicely formatted and complete, but all internet refs need URL, title, author if known, publisher and date accessed. {{cite web}} and other cite templates may be helpful. See WP:CITE and WP:V
  • There are a large number of one or two sentence paragraphs that interrupt the flow of the article - these should be combined with others or expanded where possible. Does Use in psorts really need its own section? Could this be combined with another section?
  • Article is short - while length is not an FA requirement, comprehensiveness is. I note that the approval of the FDA in the US is mentioned, but not its approval in other countries.
  • See also is mostly for articles not already linked in the article, but Tadalafil (Cialis) and Vardenafil (Levitra) are linked at least twice each already.

Hope this helps. If my comments are useful, please consider peer reviewing an article, especially one at Wikipedia:Peer review/backlog (which is how I found this article). Yours, Ruhrfisch ><>°° 00:03, 11 August 2008 (UTC)[reply]